Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
NCT06486428 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-08-01
Summary
This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.
Conditions
- Small-cell Lung Cancer
Sponsors & Collaborators
-
Addario Lung Cancer Medical Institute
lead OTHER
Principal Investigators
-
Christine Lovly, MD PhD · Vanderbilt-Ingram Cancer Center, Nashville, TN
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-23
- Primary Completion
- 2026-12-31
- Completion
- 2027-06-30
Countries
- United States
Study Locations
More Related Trials
-
Once Weekly Radiation for Lung Cancer With Chemotherapy
NCT00256789 ·Status: COMPLETED ·Phase: NA
-
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
NCT06247605 ·Status: RECRUITING ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
NCT05170204 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma
NCT01439568 ·Status: COMPLETED ·Phase: PHASE2
-
Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)
NCT01487499 ·Status: TERMINATED ·Phase: PHASE3
-
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
NCT05616624 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer
NCT04890795 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Transformation Into Small Cell Lung Cancer : a Mode of Resistance to Treatment
NCT03419286 ·Status: COMPLETED
-
Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)
NCT03425825 ·Status: COMPLETED
-
Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer
NCT05882513 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
NCT04348292 ·Status: TERMINATED ·Phase: PHASE1
-
Examining Clinical Trial Participation for Small Cell Lung Cancer Patients
NCT05769504 ·Status: NOT_YET_RECRUITING
-
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
NCT06800339 ·Status: RECRUITING ·Phase: PHASE1
-
Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage
NCT03523234 ·Status: UNKNOWN ·Phase: NA
-
Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer
NCT00003692 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer
NCT04622228 ·Status: COMPLETED ·Phase: PHASE2
-
Immunotherapy as Second-line in Patient With Small Cell Lung Cancer
NCT03059667 ·Status: COMPLETED ·Phase: PHASE2
-
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
NCT06448793 ·Status: RECRUITING
-
Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy
NCT00256841 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
NCT00334815 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients
NCT03706690 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer
NCT00020202 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
NCT00040794 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer
NCT06614621 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT03382561 ·Status: COMPLETED ·Phase: PHASE2